| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ardelyx, Inc. (ARDX) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. ARDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.30M | $21.04M | - | |
| CEO | 1.74M | $11.09M | -41,666 | |
| Other | 409.9K | $2.61M | - | |
| CFO | 409.1K | $2.61M | - | |
| Other | 339.5K | $2.16M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2018 | Rosenbaum David P.59 | Chief Development Officer | Sell | 5,570 | $2.84 | $15,818.80 | -3.3% | |
| Nov 12, 2018 | Sandell Scott D55 | 10% Owner | Sell | 592 | $2.98 | $1,766.76 | -100% | |
| May 30, 2018 | Ringold Gordon | Director | Buy | 10,000 | $4.00 | $40,000.00 | +66.7% | |
| Oct 24, 2017 | Seeto Reginald76 | Chief Operating Officer | Sell | 10,008 | $5.20 | $52,042.60 | -6.3% | |
| Aug 30, 2017 | Baskett Forest53 | 10% Owner | Sell | 485 | $4.95 | $2,400.75 | -100% | |
| Apr 18, 2017 | Rosenbaum David P.59 | Chief Development Officer | Sell | 2,051 | $11.98 | $24,577.34 | -4.9% | |
| Mar 10, 2017 | Rosenbaum David P.59 | SVP, Drug Development | Sell | 1,000 | $13.48 | $13,482.30 | -43.9% | |
| Mar 3, 2017 | Caldwell Jeremy S | EVP, Chief Scientific Officer | Sell | 1,026 | $14.14 | $14,511.85 | -5.4% | |
| Mar 1, 2017 | Jacobs Jeffrey W66 | SVP, Technical Operations | Sale+OE | 3,000 | $13.70 | $41,100.00 | -4.2% | |
| Feb 1, 2017 | Jacobs Jeffrey W66 | SVP, Technical Operations | Sale+OE | 3,000 | $12.00 | $36,000.00 | -4.3% |